Norwegian University of Science and Technology's Teri S Krebs and Pål-Ørjan Johansen have published a new article titled "Over 30 million psychedelic users in the United States", in which they have made use of data from the 2010 National Survey on Drug Use and Health (NSDUH) involving more than 57,000 people to estimate the lifetime prevalence of psychedelic use.
The authors estimate that approximately 32 million people have used LSD (lysergic acid diethylamide), psilocybin ("magic mushrooms"), or mescaline (peyote and other cacti) in their lifetime. This includes 17% of US adults aged 21 to 64 years. The highest rate of psychedelic use was in the 30 to 34 age group, with an overall rate of 20%, or 26% of males and 15% of females.
Drug Abuse
The use of Drugs for reasons other than its prescribed recommendation, is known as Drug abuse or substance abuse. Drug abuse or substance abuse is initiated by various biological and social factors.
Advertisement
"Lifetime use of psychedelics doesn't seem to have changed much since the sixties - psychedelics continue to be widely used in the US and worldwide," the researchers say.
The mechanisms of action, subjective effects, and risk profile of the classical serotonergic psychedelics, distinguish them from other drugs, the authors wrote.
![Trauma Care]( "Trauma Care")
Accident and trauma care is an important public health challenge that requires immediate attention. Injury (trauma) is the leading cause of death for all age groups under the age of 44.
"Psychedelics are different from other drugs, in that they are not known to be physically harmful or cause addiction or compulsive use. Experts agree that psychedelics are less harmful than alcohol and most other recreational drugs, although psychedelics can elicit anxiety and confusion during the drug effects", the researchers say.
The authors estimated that older adults were more likely to have used LSD and mescaline, whereas younger adults were more likely to have used "magic mushrooms". In addition, the authors note that use of "magic mushrooms" is known to have increased since the 1970s.
"People often report mystical experiences as a major reason for using psychedelics. Archaeological evidence shows that psychedelic plants have been used in the Americas for over 5000 years, and currently around 300,000 people in the US enjoy a recognized religious freedom right to use psychedelics." Krebs and Johansen said.
Source: Eurekalert
Trauma Care
Accident and trauma care is an important public health challenge that requires immediate attention. Injury (trauma) is the leading cause of death for all age groups under the age of 44.
Advertisement
"Psychedelics are different from other drugs, in that they are not known to be physically harmful or cause addiction or compulsive use. Experts agree that psychedelics are less harmful than alcohol and most other recreational drugs, although psychedelics can elicit anxiety and confusion during the drug effects", the researchers say.
The authors estimated that older adults were more likely to have used LSD and mescaline, whereas younger adults were more likely to have used "magic mushrooms". In addition, the authors note that use of "magic mushrooms" is known to have increased since the 1970s.
"People often report mystical experiences as a major reason for using psychedelics. Archaeological evidence shows that psychedelic plants have been used in the Americas for over 5000 years, and currently around 300,000 people in the US enjoy a recognized religious freedom right to use psychedelics." Krebs and Johansen said.
Source: Eurekalert
Advertisement
 Drug Abuse Screening TestDrug Abuse Screening Test (DAST) is a screening test to find out if you need professional help with 'Drug Abuse' problem. This is only an anonymous self test. | Advertisement
|
Advertisement
Recommended Readings
Latest Alcohol & Drug Abuse News
The United States is currently witnessing its highest overall mortality rates in over a century, driven in part by the surge in drug overdose fatalities.
Deciphering genetic factors in brain responses to METH and COC enables personalized approaches to combat drug abuse.
Giving rats DORA-12 during oxycodone withdrawal reduced future drug-seeking behavior, showing promise for preventing opioid addiction and relapse in humans.
Rising to 9.6% in 2021, daily vaping among New Zealand's 14-year-old students underscores a concerning youth trend.
The research also revealed a 22 percent increase in cadmium levels among marijuana users.
